CCL2 and COVID-19: Surprisingly, HUVECs incubated with severe COVID-19 serum also showed a decrease in the expression of CCL2, IL6, TNFa, PTGS2, and ITGAM compared with the control that received or did not receive pretreatment with PC (Figure 4A–E).